BioPerfectus is committed to ongoing technological innovation and proudly offers the HPV 21 Type-specific Viral Loads Detection System to the world.

In July 2023, Mette Tranberg and others published a study titled "Value of a catch-up HPV test in women aged 65 and above: A Danish population-based nonrandomized intervention study" in the "PLOS Medicine" journal with an impact factor of 15.8.

Sexually transmitted diseases (STDs) are quite prevalent, and many individuals infected with STDs may not display any noticeable symptoms.

Dengue fever will become a major threat in the southern United States, southern Europe, and new parts of Africa this decade, the WHO's chief scientist said, as warmer temperatures create the conditions for the mosquitoes carrying the infection to spread.

The epidemiology of human papillomavirus (HPV) in women has been well documented. Less is known about the epidemiology of HPV in men. Laia Bruni and his colleagues published a research study titled "Global and regional estimates of genital human papillomavirus prevalence among men: a systematic review and meta-analysis" in "The Lancet Global Health" (Impact Factor: 34.3). The aim of this study is to provide updated global and regional pooled overall, type-specific, and age-specific prevalence estimates of genital HPV infection in men.

BioPerfectus made a notable impression at the 20th Members' Meeting of the RHSC.

Extended genotyping presents a cost-effective, risk-based strategy for primary cervical cancer screening.

September is Gynecologic Cancer Awareness Month! Join us in raising awareness this month.

HPV semen infection, regardless of HPV type and exact location of the virions, significantly impairs spermatozoa’s progressive motility, morphology, and immotile sperm rate.

Today serves as a reminder to prioritize sexual health and foster positive attitudes toward consent.